HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Saussy, D. L. Articles by Halushka, P. V. Search for Related Content PubMed PubMed Citation Articles by Saussy, D. L., Jr Articles by Halushka, P. V. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 261, Issue 7, 3025-3029, 03, 1986

Identification of a putative thromboxane A2/prostaglandin H2 receptor in human platelet membranes

DL Saussy Jr, DE Mais, RM Burch and PV Halushka

The binding of the competitive thromboxane A2/prostaglandin H2 (TXA2/PGH2) antagonist (9,11-dimethylmethano-11, 12-methano-16-(3-aza- 15 alpha beta-omega-tetranor-TXA2) ([125I]PTA-OH) to membranes prepared from human platelets was characterized. [125I]PTA-OH binding to membranes from human platelets was saturable, displaceable, and dependent on protein concentration. Scatchard analysis of equilibrium binding carried out at 30 degrees C revealed one class of binding sites with a Kd of 30 +/- 4 nM and a Bmax of 1.8 +/- 0.3 pmol/mg of protein (n = 5). Kinetic analysis of the binding of [125I]PTA-OH at 0 degrees C yielded a k1 of 1.35 X 10(6) M-1 min-1 and a k-1 of 0.032 min-1, Kd = k- 1/k1 = 24 nM. The potencies of a series of TXA2/PGH2 antagonists as inhibitors of [125I]PTA-OH binding was correlated with their potencies as inhibitors of platelet aggregation induced by the TXA2/PGH2 mimetic, U46619 (1 microM) (r = 0.93, p less than 0.01). A series of TXA2/PGH2 mimetics also displaced [125I]PTA-OH from its binding site, and their potencies as inhibitors of [125I]PTA-OH binding were correlated with their potencies as stimulators of platelet aggregation (r = 0.91, p less than 0.05). The IC50 values for displacement of [125I]PTA-OH by PGF2 alpha, PGD2, and the stable PGI2 analog Iloprost were greater than 25 microM, suggesting that [125I]PTA-OH does not bind to other known platelet prostaglandin receptors. These data are consistent with the notion that this binding site may represent the platelet TXA2/PGH2 receptor.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				G. W. Dorn II, M. G. Davis, and D. D. D'Angelo Structural Determinants for Agonist Binding Affinity to Thromboxane/Prostaglandin Endoperoxide (TP) Receptors. ANALYSIS OF CHIMERIC RAT/HUMAN TP RECEPTORS J. Biol. Chem., May 9, 1997; 272(19): 12399 - 12405. [Abstract] [Full Text] [PDF]

				D. D. D'Angelo, J. J. Eubank, M. G. Davis, and G. W. Dorn II Mutagenic Analysis of Platelet Thromboxane Receptor Cysteines J. Biol. Chem., March 15, 1996; 271(11): 6233 - 6240. [Abstract] [Full Text] [PDF]